Mergers & Acquisitions

Topics also related to M&A:

Akzo Nobel CEO solicited for Axalta bid worth more than $7 bln -Bloomberg

Sept 1 - Akzo Nobel NV Chief Executive Ton Buechner has been solicited for a deal to buy car paint coatings company Axalta Coating Systems for more than $7 billion, Bloomberg reported citing people familiar with the matter.

UPDATE 1-EU seeks rivals' feedback on Facebook, WhatsApp deal

* Commission decision expected by Oct. 3 (Recasts, adds Commission questionnaire)

RLPC-Imperial Tobacco closes $13 bln of loans

LONDON, Sept 1 - British cigarette maker Imperial Tobacco has closed loans of about $13 billion to back its acquisition of selected brands and assets from Reynolds American Inc, the lead banks said on Monday.

European shares edge higher, Novartis leads drugmakers

LONDON, Sept 1 - European shares edged higher to close near a recent one-month peak on Monday, with merger and acquisition speculation about British broadcaster ITV helping media stocks and Novartis leading drugmakers.

UPDATE 2-Iliad still in the hunt for T-Mobile US

* Iliad in talks with partners possibly to improve its bid

European shares tick higher, drugmakers advance

LONDON, Sept 1 - European shares traded near a recent one-month peak on Monday, with merger and acquisition speculation about British broadcaster ITV helping media stocks and Novartis leading drugmakers.

EU decision on Zimmer's $13.4 bln Biomet deal expected by Oct. 3

BRUSSELS, Sept 1 - European Union antitrust regulators will decide by Oct. 3 whether to give the green light to U.S. orthopaedic products maker Zimmer Holdings' $13.4 billion takeover of rival Biomet Inc.

UPDATE 2-South Africa's Bidvest considers London listing for food busines

* Headline EPS at 1,723 cents, against forecast of 1,751 cents (Recasts, adds CEO comment, background)

EU regulators set Oct. 3 deadline for Eli Lilly, Novartis deal

BRUSSELS, Sept 1 - European Union competition regulators have until Oct. 3 to decide whether to approve U.S. drugmaker Eli Lilly and Co's $5.4 billion bid for Swiss peer Novartis's animal health business.

Iliad says still working on T-Mobile US acquisition

PARIS, Sept 1 - French low-cost telecom operator Iliad said it would continue its pursuit of T-Mobile US even though the owner of the U.S. fourth-place mobile operator, Deutsche Telekom, had rebuffed its first bid as too low.

Photo

Is U.S. economic patriotism hurting?

Any Americans believing that their country is being bought up by the Chinese might want to think again, according to the Vale Columbia Center on Sustainable International Investment.

Topics also related to M&A: